Welcome to A.Catalyst network partnering application portal. To learn more about AstraZeneca A.Catalyst Network, please visit https://www.astrazeneca.com/partnering/a-catalyst-network.html
Application requirements:
In your pitch deck/presentation, please cover the following aspects, as applicable:
-
disease area
-
alignment with AstraZeneca's business priorities
-
novelty of the proposal
-
scalability
-
target audience
-
market share potential
-
business model
-
commercial strategy
-
team expertise
-
IP protection
-
time lines for go-to-market
-
commercial and operational risks
-
project KPIs
Please identify a pain point/problem in the patient journey your proposal will address. If possible, please add relevant data to support and demonstrate the magnitude of this pain point.
Our 2023 priorities:
Growth and Therapy Area Leadership:
-
Improve early diagnosis of chronic kidney disease
-
Transition hyperkalemia diagnosis from reactive to proactive
-
Establish a referral network to support patients with FXai-related bleeding
-
Transform severe asthma and COPD care and treatment
-
Drive systemic lupus erythematosus awareness and early patient identification
-
Improve early detection of lung cancer
-
Scale up integrated oncology patient care management platforms
-
Activate multidisciplinary teams to deliver optimal outcomes for cancer patients
-
Reducing time to accurate diagnosis for rare disease patients
-
AI-based detection of future waves and new variants of SARS-CoV-2 infection
Science and Innovation:
-
Novel, innovative drug delivery systems and drug development platforms across a range of advanced modalities, that includes peptides, oligonucleotides and antibodies
-
To develop Cell Therapies as Regenerative Medicines, this includes approaches to regenerate new tissue, modulate the immune system and remove disease causing cells.
-
The generation of hypoimmunogenic ‘universal cells’ and novel scalable bioprocesses to produce high quality cells for therapeutic use.
The form and all accompanying materials must be submitted in English.
When you are ready to apply, please click the "Submit a proposal" button below to begin.
What's next?
Your submission will be reviewed by a dedicated team of experts. Please note that their review might take up to 2 months. If we require any additional information, you will be contacted using the contact information you provided in your application.
For more information on AstraZeneca's privacy policy please visit: https://www.globalprivacy.astrazeneca.com/
About A.Catalyst
A.Catalyst Network is an interconnected global network of more than 20 AstraZeneca health innovation hubs, made up of physical locations and virtual partnerships. The network embodies our commitment to Growth Through Innovation as 'a catalyst' for the development of new healthcare solutions to support patients.
Through our A.Catalyst Network we are co-creating challenge-based solutions with and for patients, and working with partners to establish integrated healthcare systems that benefit the whole patient experience — from prevention and awareness, diagnosis and treatment to post-treatment and wellness.
Why partner with us
A.Catalyst Network enables AstraZeneca to work with and provide support to start-up companies, research organizations and technology partners through mentoring, advice and incubator/accelerator models to help them bring their ideas to life across the globe.
Each A.Catalyst Network hub has its own unique ecosystem, addresses different challenges, and can take different forms, according to its specific characteristics and needs. This can include shared physical locations with emerging companies and academic groups, experience design and co-creation centres in partnership with healthcare practitioners, patients and entrepreneurs, start-up acceleration and incubation sites, educational programmes, mentoring, internships, roadshows, professional and patient services.
While each hub is unique, they are all interconnected as part of a global network. This means partners and solutions are not restricted to a single hub and can move fluidly between hubs as required.
Our 2021 priorities
Delivering growth and therapy area leadership:
-
Improve early diagnosis of chronic kidney disease
-
Transform severe asthma care and treatment
-
Drive systemic lupus erythematosus awareness and early patient identification
-
Improve early detection of lung cancer
-
Scale up integrated oncology patient care management platforms
-
Activate multidisciplinary teams to deliver optimal outcomes for cancer patients
Accelerating innovative science:
-
Support the development of Regulatory T cell therapy for treatment of immune-mediated diseases
-
Identify sources of biological samples from diverse genetic backgrounds to enhance disease understanding
-
Generating multi-omics data in specific patient cohorts including NASH, rare cardiovascular diseases and immunological conditions
-
Innovations in delivery of new modalities; peptides, oligos and antibodies across oncology, cardiovascular, renal and respiratory diseases
-
Utilisation of digital biomarkers and digital therapeutics that can improve patient-centric outcomes in heart failure and renal disease
If you wish to collaborate with AstraZeneca for basic scientific research, including for projects outside the above-listed priorities, please visit our Open Innovation website for an overview of the offerings.
What’s next?
We are pleased that you wish to submit a proposal to the A.Catalyst. To make the submission process as easy as possible, you need your pitch deck. We request a little additional information which you will be able to enter on our online submission form. The form and materials should be submitted in English. Your submission will be reviewed by dedicated team of experts. Please note that review might take up to 2 months.
When you are ready, click the "Submit a proposal" button below to begin.
For information on how AstraZeneca uses your personal data please visit: https://www.globalprivacy.astrazeneca.com/
Just a moment, the page is loading...
